Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Policy / Pricing

CMS and FDA Announce RAPID Coverage Pathway to Accelerate Patient Access to Life-Changing Medical Devices

 April 23, 2026

FDA

CMS and FDA announce the Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway, a new pathway designed to expedite access to certain FDA-designated Class II and Class III

Policy / PricingRead full story

Post navigation

Unnamed pharma files citizen petition targeting FDA’s trove of rejection letters →
← Sanofi defends Dupixent patents, but execs insist it has nothing to do with CEO change

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com